Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

MODERNA Stock Plunges as Public Loses Interest in More Covid Jabs

Moderna may be riding a wave with third quarter earnings report higher than expected, but all the same, it’s still posting losses to the tune of a 15% plunge. The company is blaming a stockpile of unused COVID vaccines and consumer lack of interest in the shots for the downturn and is projecting lower returns for 2024. So far, the losses per share are $9.53, with $43 billion less in return than expected. According to CNBC, Moderna’s stock is down more than 57% overall for the year...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports